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Abstract
Background: As the use of microarray technology becomes more prevalent it is not unusual to
find several laboratories employing the same microarray technology to identify genes related to the
same condition in the same species. Although the experimental specifics are similar, typically a
different list of statistically significant genes result from each data analysis.
Results: We propose a statistically-based meta-analytic approach to microarray analysis for the
purpose of systematically combining results from the different laboratories. This approach provides
a more precise view of genes that are significantly related to the condition of interest while
simultaneously allowing for differences between laboratories. Of particular interest is the widely
used Affymetrix oligonucleotide array, the results of which are naturally suited to a meta-analysis.
A simulation model based on the Affymetrix platform is developed to examine the adaptive nature
of the meta-analytic approach and to illustrate the usefulness of such an approach in combining
microarray results across laboratories. The approach is then applied to real data involving a mouse
model for multiple sclerosis.
Conclusion: The quantitative estimates from the meta-analysis model tend to be closer to the
"true" degree of differential expression than any single lab. Meta-analytic methods can
systematically combine Affymetrix results from different laboratories to gain a clearer
understanding of genes' relationships to specific conditions of interest.
Background
Microarray technology allows simultaneous assessment of
transcript abundance for thousands of genes. This exciting
research tool permits the identification of genes which are
significantly differentially expressed between conditions.
With the use of microarrays becoming more common-
place, it is not unusual for several different laboratories to
investigate the genetic implications of the same condi-
tion(s). Each lab may produce its own list of candidate
genes which they believe to be related to the condition of
interest. As a result of sound statistical approaches, each
lab will also have for each candidate gene some quantita-
tive measure that serves as the basis for the claim of statis-
tical significance.
Of interest in this paper are the methods by which these
quantitative measures may be combined across labs to
arrive at a more comprehensive understanding of the
effects of the different candidate genes. Where the term
"analysis" is used to describe the quantitative approaches
to draw useful information from raw data, the term
"meta-analysis" [1] refers to the approaches used to draw
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useful information from the results of previous analyses.
Meta-analysis has been predominantly used in the medi-
cal and social sciences, in situations where several studies
may have been conducted to investigate the effect of the
same treatment, and the researcher seeks to combine the
results of the different studies in a meaningful way in
order to arrive at a single estimate of the true effect of the
treatment. For the current application, meta-analytic
approaches can be employed to combine the results from
several different labs without having access to the original
raw data that yielded the initial results. Such approaches
have particular utility with the results of Affymetrix Gene-
Chip®  microarrays and other fabricated arrays, where
results are given in a uniform format that readily lends
itself to comparison between labs and combination across
labs.
A measure of the degree or magnitude of differential
expression provides more information regarding a gene's
relation to a disease or condition of interest than does a
statement regarding its significance or nonsignificance.
This information is useful because it allows for greater pre-
cision of estimation of the gene's effect with respect to the
condition of interest. That is, to arrive at a clearer under-
standing of a gene's true effect relating to the condition of
interest, it is most helpful to have a quantitative measure
of the magnitude of differential expression rather than a
simple declaration of significance.
Prior applications of meta-analysis to microarray data
have either sought to combine P-values or to combine
results across platforms (i.e., combining Affymetrix and
cDNA array results) [2-6]. Combining only P-values,
while useful in obtaining more precise estimates of signif-
icance, does not provide information that is easily inter-
pretable by a biologist, may not indicate the direction of
significance (e.g., up- or down-regulation), and most
importantly, gives no information regarding the magni-
tude of the estimated expression change. Similarly, while
a "vote-counting" approach based on P-values [6]
addresses differences in lists of significant genes from sep-
arate experiments, it gives no information regarding the
magnitude of the estimated expression change. While an
"integrative correlation" approach [5] will help identify
genes with reproducible expression patterns, it also does
not provide any information regarding the magnitude of
the estimated expression change
Previous attempts to combine results across microarray
platforms (i.e., technologies) assume that spot intensities
or signal values for a given gene can be directly compared
even though they represent different segments of the gene.
That is, a spot for a given gene on a cDNA array represents
the entire gene, while each spot for the same gene on an
Affymetrix array represents a specific small section of the
gene. Thus, combining results across technologies using
only spot intensities is problematic from a biological per-
spective because the measurements represent different
physical quantities. Even if the average spot intensity on
an Affymetrix array is used, it is not certain that this aver-
age spot intensity value is at all comparable to the spot
intensity value of the gene on a cDNA array.
Moreau et al. [4] report that 'after appropriate filtering,
ratio and intensity data from different platforms can be
compared and are amenable to' be used in a meta-analy-
sis. However, "filtering", or "averaging out" outliers or
non-reproducible spots, requires some subjectivity in the
method of choice and may force agreement between plat-
forms where no agreement should exist due to fundamen-
tal technological differences. Parmigiani et al. [5] attempt
to address this problem of cross-platform consistency by
identifying a set of genes whose expression patterns are
essentially reproducible across platforms. However, even
for these "reproducible" genes, there remains the question
of how to systematically combine their corresponding
results from the several laboratories to arrive at a single
quantitative measure of differential expression. At the very
least, if results are to be combined across platforms in a
meta-analysis, the use of covariates [7] should be
employed to account for the underlying differences
between oligonucleotide (e.g., Affymetrix) and cDNA
platforms. The focus of the current application is restricted
to standard Affymetrix microarray results, and a method
to combine results across laboratories is proposed and
evaluated.
Results
Affymetrix technology
The Affymetrix GeneChip® microarray [8] represents indi-
vidual genes by 25-mer segments (probes) fixed to the
chip, and also makes use of mismatch probes differing at
position 13. Each gene on the chip is typically represented
by the same number of probe pairs on the chip (usually
14–20), although exceptions exist. It is now possible for
some organisms' entire genomes to be represented on a
single microarray (e.g., Arabidopsis). Appropriately pre-
pared tissue sample is hybridized to the array and the
array is scanned, producing raw data consisting of the
intensities of the individual spots on the array. These
intensities come in pairs, with PM denoting the intensity
of a perfect-match probe and MM denoting the intensity
of the corresponding mismatch probe.
Affymetrix algorithms
Affymetrix has developed statistical algorithms [9] that
employ these individual spot intensities for the purpose
of estimating the true expression levels of individual genes
in single samples. Furthermore, the Affymetrix approach
compares gene expression levels in two different tissuesBMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
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(samples or treatment conditions) and reports a "signal
log ratio" (SLR) with 95 percent confidence bounds. The
signal log ratio is the signed Iog2 of the signed fold change
(FC) familiar to biologists [9]. That is, FC = 2SLR if SLR ≥  0
and  FC  = (-1)2-SLR if  SLR  < 0. The algorithm used by
Affymetrix to compute the SLR is based on Tukey's
biweight algorithm [10] and for each gene takes a
weighted average of the log2 of the ratio of PM  -  MM
between treatments or conditions, with weights related to
the deviations from the median log2 ratio for the gene, and
with adjustments made when PM  <MM. The resulting
weighted average is the SLR.
Between the two conditions of interest, each gene either
changes its level of expression or the level remains the
same. A declaration of significant differential expression
results from sufficient evidence that the gene is not
expressed the same in the two conditions (i.e., that the
SLR differs significantly from zero). Tukey's biweight algo-
rithm provides an estimate for the variability of the SLR
and an approximate distribution for the SLR estimate. The
Affymetrix software (Microarray Suite Version 5.0, or MAS
5.0) reports a 95 percent confidence interval for the SLR
[11], from which the estimated standard error can be
computed. Individual laboratories can use this informa-
tion to make a declaration of significant differential
expression.
It should be noted that this SLR estimate represents a
measure of differential expression between two chips
(generically referred to as a base sample chip and an
experimental sample chip). In practice, of course, it is rec-
ommended that experiments involve more than two
chips, but the current MAS 5.0 algorithm is designed to
represent differential expression only between two chips
at a time. Other approaches exist to measure differential
expression (dChip [12] and RMA [13], for example), and
future work will evaluate their performance in meta-anal-
yses. However, for the purposes of this current work, the
focus of differential expression will rely on the SLR esti-
mate of differential expression between two chips,
because these are the estimates provided automatically by
the commercial MAS 5.0 software.
If we let   denote the estimate of the SLR θ i,k for gene k
in lab i, and   be the upper bound for the 95 percent
confidence interval for the same, then both   and
 are reported by the Affymetrix software. The
Affymetrix documentation [9] gives the estimated stand-
ard error of   as si,k = (  -  ) / ti,k(.975), where
ti,k(.975) is the upper .025 critical value of the t distribu-
tion with dfi,k degrees of freedom, where dfi,k = max(0.7(ni,k
- 1), 1), with ni,k representing the number of probe pairs
representing gene k on each array in study i. The estimated
variance of the SLR estimate   is vi,k = .
Accordingly, lab i could then test for significant differen-
tial expression of gene k (i.e., test the hypothesis  : θ i,k
= 0) by use of the test statistic Ai,k = /si,k. Under  ,
Ai,k  approximately follows the t  distribution with dfi,k
degrees of freedom. The significance P-value (Pi,k) for gene
k in lab i is the value such that |Ai,k| is the upper Pi,k/2 crit-
ical value of the t distribution with dfi,k degrees of free-
dom, and   is rejected at the α i,k level if Pi,k <α i,k. That
is, if Pi,k is sufficiently small, then lab i would declare gene
k significantly differentially expressed.
Meta-analysis
The general meta-analytic framework [7] assumes that a
measurable relationship exists between certain quantities
of interest, and n  independent studies have been con-
ducted to examine this relationship. In turn, this relation-
ship can be quantified so that each study produces an
estimate of the relationship. If the estimates are appropri-
ately standardized, then each study's estimate can be
termed an "effect size" estimate. An effect size is essen-
tially a standardized quantitative expression of the rela-
tionship of interest. For example, several different
laboratories may investigate which of two drugs are better
at treating a particular disease. In this case, the relation-
ship of interest is the difference between the drugs' effects.
If each laboratory produces an estimate standardized such
that estimates from all laboratories address the same
quantity and are on the same scale, then these estimates
are effect size estimates.
There are three main classes of effect size estimates [14].
The first and perhaps most common is the standardized
difference estimate, such as Hedges's g, similar to the t-sta-
tistic in a two sample study:  . The sec-
ond is the standardized relation estimate, such as the
sample correlation coefficient r. The third is the measure
of significance, such as the P-value from a particular
hypothesis test. (Although not an effect size in the tradi-
tional sense, the measure of significance approach is men-
tioned here for the sake of completeness.)
In order to be combined across studies, effect size esti-
mates must address the same measure or quantity, be
standardized, and (with the exception of P-values, which
are combined differently [15]) include some measure of
variability of the effect size estimate [16]. Once each study
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i has provided its effect size estimate   and its measure of
variability  vi, a meta-analysis can be performed. Three
main meta-analytic approaches exist: fixed effects, ran-
dom effects, and hierarchical Bayes. The first two
approaches are summarized here in order of increasing
complexity, and the third is the subject of Choi et al. [3]
and a future research interest. The three approaches are
discussed more fully in Cooper and Hedges [14] and
DuMouchel and Normand [17].
Fixed effects meta-analysis model
Assume that n independent studies have provided effect
size estimates   and measures of variability vi, i = 1, ..., n.
The most general meta-analytic approach assumes that
with sampling error ε i ~ N(0,  ). That is, each   is an
estimate of a true fixed underlying effect size θ i, and it is
assumed that θ 1 = ... = θ n with the common value θ . This is
referred to as the homogeneity assumption and can be
interpreted as assuming that all studies examined and pro-
vided estimates of the same parameter θ , and any differ-
ences between the estimates are attributable to sampling
error alone. This common value parameter θ  is estimated
as a weighted average of the effect size estimates:
The weights wi are chosen to minimize the variance of  ,
and this is achieved by  , where vi is the estimated
variance of  . The variance of   is  .
The underlying assumption of homogeneity  : θ 1 = ... =
θ n can be tested by use of the test statistic
Under ,  Q is approximately distributed as  . Then
this χ 2 distribution can serve as the basis for an approxi-
mate test of homogeneity. If Q is larger than the upper α Q
critical value of the   distribution,   is rejected at
the α Q level. Alternatively, the homogeneity P-value PQ is
the value such that Q is the upper PQ critical value of the
 distribution, and   is rejected at the α Q level if PQ
<α Q.
The test of significance  : θ  = 0 can be considered by
use of the test statistic  . Under  , Z is dis-
tributed as N(0, 1), and if |Z| is larger than the upper α Z/
2 critical value of the N(0,1) distribution,   is rejected
at the α Z level. Alternatively, the significance P-value PZ is
the value such that |Z| is the upper PZ/2 critical value of
the N(0, 1) distribution, and   is rejected at the α Z level
if PZ <α Z.
Meta-analysis in the context of a microarray experiment
assumes that several laboratories have provided quantita-
tive measurements of differential expression (the effect
size) for a number of genes along with variability esti-
mates. For the fixed effects model, the homogeneity
assumption ( ) provides that for each laboratory the
gene is expressed the same, and differences between labo-
ratories are due to sampling error only. On the other
hand, the hypothesis   has the biological interpreta-
tion that there is no change in gene expression between
the conditions of interest. This test of significance identi-
fies genes that are significantly differentially expressed
between the two conditions, using information from mul-
tiple laboratories.
Random effects meta-analysis model
In practice, the homogeneity assumption (and the result-
ing fixed effects model) tends to be overly simplistic but is
presented in this paper for the sake of completeness. This
assumption can be relaxed to make the meta-analysis
model more appropriate. The basic random effects model
[18] assumes n independent studies have provided effect
size estimates   and measures of variability vi, i = 1, ..., n.
In addition, the model assumes that
In this framework, θ  is the population mean effect size,
and there are two error components, δ   and  ε ,
corresponding to between-study and within-study varia-
bility, respectively. Each study seeks to make statements
regarding this quantity θ , and so takes a sample of individ-
uals from a certain population in order to study the under-
lying effect size θ . However, due to differences between
studies such as time, location, equipment, and other
uncontrollable (and possibly unknown) factors, each
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study will in fact be estimating a slightly different quan-
tity. That is, due to differences between studies, study i is
estimating θ i, a random effect size from the population of
all possible effect sizes. The error component δ i ~ N(0, ∆ 2)
is the random deviation of θ i from θ  (representing varia-
bility between studies). In this basic model, ∆ 2 represents
the random variation between studies. Within study i, the
actual estimate   will vary from the "true" effect size θ i
based on which random sample is selected. That is, repli-
cates within a study will result in slightly different esti-
mates of the effect size due to sampling error. Here, ε i ~
N(0,  ) is sampling error (representing variability
within study i).
Q is calculated as in the fixed effects model. (Note that the
fixed effects model   assumes that ∆ 2 = 0.) The random
effects model uses this Q value to calculate new weights
, where
Then the meta-analysis estimate for the population mean
effect size θ  is
The variance of   is  . The test of signifi-
cance   :  θ  = 0 can be considered by use of the test sta-
tistic .  Under  ,  Zw is distributed as
N(0, 1), and the significance P-value is calculated in the
same manner as in the fixed effects model.
When the random effects meta-analysis is applied in the
context of a microarray experiment, again it is assumed
that several laboratories have provided quantitative meas-
urements of differential expression (the effect size) for a
given gene along with variability estimates. The random
effects model assumes that there is some true degree of
differential expression for the gene, and each lab is actu-
ally estimating a slightly different true degree of differen-
tial expression. That is, each laboratory has a slightly
different "true" degree of differential expression. In addi-
tion, the estimate from each laboratory varies randomly
about its true degree of differential expression due to sam-
pling error. Then ∆ 2 is a measure of the amount of varia-
tion between the laboratories' true degrees of differential
expression, and the test of significance is used to identify
differentially expressed genes by using information across
multiple laboratories.
Meta-analysis with Affymetrix data
Our motivation for applying meta-analytic techniques to
microarray data is threefold. First, standard platforms
(e.g., Affymetrix) make combining results across labs
straightforward and eliminate the usual criticism of meta-
analyses that "apples and oranges" are being mixed [16]
because the estimates being combined across labs have
each been standardized by the same algorithms [9] in
such a way that they are in fact estimates of the same
underlying effect. Furthermore, any known differences
between laboratories such as sample tissue type can be
incorporated into the meta-analysis by use of covariates
[7]. Second, combining raw data may provide more infor-
mation than combining results, but raw data are not
always easy to obtain, and it is conceivable that raw data
may become unavailable while published (or unpub-
lished) results are available. Third, if it can be shown that
meta-analysis produces similar results to the pooling of
raw data, then it can be argued that meta-analytic
approaches are more efficient in the sense that they only
require easily obtainable results rather than the raw data.
The uniformity of chip design and data acquisition from
Affymetrix oligonucleotide microarray experiments read-
ily lends itself to a meta-analysis. Given n studies examin-
ing the differences in gene expression between two
treatments (e.g., healthy vs. diseased), a meta-analysis can
combine each study's signal log ratio (SLR) estimates in a
meaningful way by taking the SLR as the effect size esti-
mate. The SLR satisfies the criteria for an effect size (i.e.,
comparability of estimates, standardization to the same
scale, and availability of a variance estimate). The SLR for
a given gene represents the degree of differential expres-
sion between two conditions, and is directly comparable
between labs since it estimates the same physical quantity.
The SLR from Affymetrix is standardized in the sense that
a SLR of zero means no differential expression is observed,
and the algorithms used to produce the SLR place all SLR
estimates on the same scale. Finally, a variance for the SLR
estimate is provided by the Affymetrix algorithms [9,10].
A general fixed effects model can be employed to perform
a meta-analysis to estimate the true effect size (signal log
ratio, SLR) θ k of gene k. In addition, the test of homogene-
ity can be evaluated to determine whether the n studies are
in fact estimating the same true underlying value of θ k, i.e.,
whether θ 1,k = ... = θ n,k. If this homogeneity assumption is
found to be reasonable, then a test of significance can be
considered to determine whether the true signal log ratio
θ k is significantly different from zero (i.e., whether gene k
is significantly differentially expressed between the two
conditions). If the homogeneity assumption is deemed
unreasonable, then the random effects model can be
employed to account for inter-study variability.
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Simulation example
In order to evaluate the usefulness of this meta-analytic
approach, a simulation study was conducted. The purpose
of this simulation study was to illustrate how the results
of the meta-analysis compare with the actual ("truth")
simulation setting. A simple simulation model was devel-
oped with the sole purpose of generating "raw" probe-
level data with certain genes "known" to be differentially
expressed. While this model may not account for all
sources of possible variability, it is nonetheless adequate
for the purposes of the current work.
Simulation model
"Raw" probe-level data were generated from a model
assuming that mismatch intensities (MM) are random
background noise, which is an underlying assumption of
the Affymetrix approach [9]. Our investigation of real data
indicated that mismatch intensities appear to follow a
long-tailed Gamma distribution. Based on this, a random
mismatch intensity is simulated for each probe l of each
gene k such that MMkl ~ Gamma(α , β ), with mean   and
variance [19].
In this simulation, larger values of the shape parameter α
indicate more signal being detected by mismatch probes,
with the peak of the distribution of MM intensities being
moved away from zero. Larger values of the scale parame-
ter β  make high MM intensities less likely by pulling in the
tail of the distribution. For the purposes of this simula-
tion, it was assumed that mismatch intensities did not
vary across labs or treatments.
Once the background mismatch intensities were
obtained, the perfect match (PM) intensities were gener-
ated via the model
Yijkl = µ + Li + Gk + P(G)(k)l + LGik + ρ k(Tj + LTij + TGjk + LTGijk
+ TP(G)j(k)l) + ε (ijk)l   (7)
where Yijkl is the log2 of the PM - MM difference for probe
l of gene k under treatment j in lab i. N labs were consid-
ered with each lab using the same two treatments. The
term  ρ k  ~  Bernoulli(p) is 1 if gene k  is differentially
expressed between conditions j = 1 and j = 2, and is 0 oth-
erwise. The parameter p corresponds to the percentage of
genes that are differentially expressed, with higher values
resulting in more differentially expressed genes. In this
model, Li is the effect of lab i, Tj is the effect of treatment j,
Gk is the effect of gene k, P(G)(k)l is the effect of probe l of
gene k, ε (ijk)l is a random error term, and the other terms
are interaction effects. To introduce more between-lab
variability, the error variance was allowed to be different
in each lab. That is, ε (ijk)l ~ N(0,  ) for the error terms in
lab i. Each term (X) in the model is assumed to be a ran-
dom effect from a N(0,  ) distribution, except for the
constant µ, the fixed effect Tj, and the ρ k term. The param-
eters p, µ, Tj, σ 1, ..., σ N, and σ X for X = L, G, P(G), LG, LT,
TG, LTG, and TP(G) can be adjusted to introduce various
sources of variability in the "observed" simulated data.
These simulated data can be used to generate "observed"
SLR estimates for each gene in each lab. These "observed"
SLR estimates can then be combined systematically in a
meta-analysis. Note that the "true" SLR value for each
gene can be obtained by using the same parameter values
as in the simulation model but dropping all lab and error
terms. Then the adaptive nature of the meta-analytic
approach can be illustrated by comparing the "true" SLR
values with the estimates from each lab and from the
meta-analysis models.
Simulated data
The simulation was conducted in the R environment [20]
with code requiring the use of the affy package [21] from
the Bioconductor project [22,23]. While not the purpose
of this investigation, the simulation was performed based
upon the Affymetrix rat neuro chip RN_U34 with model
parameter settings N = 6, α  = 0.1, β  = 0.0003, p = 0.05, µ
= 2.5, σ L = 0, σ G = 0.5, σ P(G) = 0.3, σ LG = 0.1, T1 = -0.2, T2 =
0.2, σ LT = 0.1, σ TG = 1.0, σ LTG = 0.13, σ TP(G) = 0.5, σ 1 = .48,
σ 2 = .60, σ 3 = .72, σ 4 = .84, σ 5 = .96, and σ 6 = 1.08. These
parameter settings were selected to produce a distribution
of MM intensities similar to that observed in real data
(Figure 1a,b) and to force the distribution of signal log
ratio (SLR) estimates to fall within a reasonable range
with some variation between laboratories (Figure 1c,d).
Most SLR estimates were near zero (Figure 1c), indicating
nondifferential expression, while some genes had larger
absolute SLR's with smaller standard errors, an indication
of significant differential expression. The data were simu-
lated such that there were similar patterns between labs
while allowing for lab differences, as evidenced by a
comparison of the SLR's from two simulated labs (Figure
1d). While the estimates from the two simulated labs were
clearly similar, there were obvious differences between the
labs, although not as different as could be observed in real
data. As a result, these two labs might produce slightly dif-
ferent lists of significantly differentially expressed genes.
The simulation parameters can be adjusted to introduce
varying degrees of difference between experiments, and
this will affect the final claim made by the meta-analysis
regarding statistical significance of differential expression.
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Summary of real and simulated RN_U34 Affymetrix chip data Figure 1
Summary of real and simulated RN_U34 Affymetrix chip data. (a) The real mismatch (MM) intensities are from a 
RN_U34 Affymetrix chip, and their histogram closely resembles a Gamma distribution with a long tail. (b) The simulated MM 
intensities are drawn from a Gamma distribution to resemble the real MM intensities. (c) The relationship between the SLR 
from a simulated lab and the standard error of the SLR for each gene on the RN_U34 Affymetrix chip. Large absolute SLR's 
with small standard errors indicate significant differential expression. (d) A comparison of SLR estimates from two simulated 
labs shows general agreement, with some differences between labs.
(a) Real MM, Single Array
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(b) Simulated MM, Single Array
Mismatch Intensities
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(c) Simulated Lab 1
SLR Estimate
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Fixed effects meta-analysis results
The results from the six simulated labs were combined
using the fixed effects meta-analysis model (Figure 2). The
test of homogeneity  : θ 1,k = ... = θ 6,k was performed
for each gene k, k = 1, ..., 1322 (the RN_U34 chip has 1322
features or reference sequences), and the P-values for each
 were summarized in a histogram of homogeneity P-
values (Figure 2a). Clearly there was widespread violation
of the homogeneity assumption, as evidenced by the
abundance of smaller homogeneity P-values.
When the False Discovery Rate (FDR) [24] was controlled
at 0.05, 88 of the 1322 genes failed the homogeneity test.
That is, there appeared to be significant interlaboratory
differences, such that the laboratories did not appear to
provide estimates of the same true degree of differential
expression for all genes. This appeared to be true for genes
across a wide range of fixed effects meta-analysis SLR esti-
mates, as evidenced by the lack of a clear relationship
between fixed-effects SLR estimates and homogeneity P-
values (Figure 2b). As a result, the random effects meta-
analysis model was deemed more appropriate to adjust
for the lack of homogeneity.
Random effects meta-analysis results
The same data from the six simulated labs were used in a
random effects meta-analysis, and the resulting SLR esti-
mates were similar to those from the fixed effects meta-
analysis (Figure 3a). The test of significance  : θ k = 0
was performed for k = 1, ..., 1322 (i.e., for all 1322 genes),
and the P-values for each value of k were summarized in a
histogram of significance P-values (Figure 3b). As a result
of the parameter selections for the simulation, an abun-
dance of small P-values was observed, indicating a large
number of significantly differentially expressed genes. A
comparison of the meta-analysis SLR estimates with the
significance P-values (Figure 3c) showed a trend of
smaller P-values for larger absolute SLR. Similar to the
results from a single lab (Figure 1c), most meta-analysis
SLR estimates were close to zero (Figure 3d), but the
standard errors were slightly lower overall for the meta-
analysis estimates, after combining the SLR estimates
across labs.
The differences between the fixed effects and random
effects models can be summarized by considering bubble
plots for a single gene (Figure 4a,b), with bubble area pro-
portional to weights used in the meta-analysis. For this
Fixed effects meta-analysis of simulated results Figure 2
Fixed effects meta-analysis of simulated results. (a) The abundance of smaller homogeneity P-values indicates wide-
spread violation of the homogeneity assumption. (b) The plot of homogeneity P-values versus fixed effects SLR estimates 
shows that this lack of homogeneity exists across a large range of SLR estimates.
(a) Fixed Effects Meta−Analysis
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Random effects meta-analysis of simulated results Figure 3
Random effects meta-analysis of simulated results. (a) A comparison of the fixed effects and random effects meta-anal-
ysis estimates of SLR shows general agreement between the models. (b) The histogram of significance P-values shows an abun-
dance of significantly differentially expressed genes, as evidenced by the large number of smaller significance P-values. (c) The 
smallest significance P-values tended to occur for genes whose random effects meta-analysis SLR estimates were large in abso-
lute value. The reference line is the P-value cut-off used to control the False Discovery Rate at 0.05. Using this cut-off, the ran-
dom effects meta-analysis declared 72 of the 1322 genes significantly differentially expressed. (d) Demonstration of how the 
SLR's estimated from the meta-analysis relate to their standard errors.
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(b) Random Effects Meta−Analysis
Significance P−values
F
r
e
q
u
e
n
c
y
0.0 0.2 0.4 0.6 0.8 1.0
0
5
0
1
0
0
1
5
0
2
0
0
●● ●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
● ● ●
●
●●
●
●
●
●
●
● ●
●
●● ● ● ● ●● ● ● ●
●
● ●
●
● ●
●
●
●
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
●● ● ● ●
●
●
●
●
●
●
●
● ●
●
● ● ●
●
●
● ●● ● ●● ● ● ●
●
●
●
●
●
●
●
●
●
●●
●
●
●
−6 −4 −2 0 2 4
0
.
0
0
0
0
.
0
0
5
0
.
0
1
0
0
.
0
1
5
0
.
0
2
0
(c) Random Effects Meta−Analysis
SLR Estimate
S
i
g
n
i
f
i
c
a
n
c
e
 
P
−
v
a
l
u
e
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ● ●
●
●
● ●
●
●
●
●
●
●
● ● ●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●●
●
●
●
● ●
●
● ●
●
●
●
●
●
● ●
● ●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
● ●
●
●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
● ●
●
● ●
●
● ●
● ● ● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
● ●
●
●
●
●
●
● ●
●
●
● ●
●
●
●
● ●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ● ●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
● ●
●
●
●
●●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ● ●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
● ● ●
●
●
●
●
●
●
●
●
● ● ●
●
●
● ●
●
●●
●
●
●
●
● ●
● ●
●
●
● ● ●
●
●
●
●
● ●
● ●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
● ● ● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
● ● ●
●
●
●
● ●
●
●
●
●
● ●
●
●
●
● ● ● ●
●
● ● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
● ●
●
●
●
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ● ●
● ● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
−6 −4 −2 0 2 4
0
.
1
0
.
2
0
.
3
0
.
4
(d) Random Effects Meta−Analysis
SLR Estimate
S
t
a
n
d
a
r
d
 
E
r
r
o
rBMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
Page 10 of 19
(page number not for citation purposes)
particular gene, laboratory 2 estimated a SLR considerably
smaller than the SLR's from the other labs with very small
variance and hence very large weight in the fixed effects
meta-analysis. As a result, the fixed effects meta-analysis
estimated the true SLR for this gene to be closest to the SLR
from lab 2. Such a result would call into question the SLR
estimate from lab 2 for this gene. The random effects
model took this lack of homogeneity into account and
appropriately down-weighted the SLR estimates for this
gene from all six labs. In particular, the weight for this
gene in lab 2 was reduced from 88.5 in the fixed effects
model to 1.8 in the random effects model. For compari-
son, the weights for this gene in the other five labs ranged
from 3.0 to 11.9 in the fixed effects model and from 1.2 to
1.6 in the random effects model. Whereas the fixed effects
model declared this gene significantly differentially
expressed, the random effects model did not (controlling
the FDR at 0.05 in both models). Thus, the random effects
model was not overly influenced by any single lab's SLR
estimate.
Comparing simulated results and "truth"
When the FDR was controlled at 0.05, 72 of the 1322
genes were declared by the random effects meta-analysis
to be significantly differentially expressed based on the
results of the test of significance  . Individually, the six
labs identified between 44 and 58 significantly differen-
tially expressed genes (controlling the FDR at 0.05 for
each lab) (Table 1). For each lab, most of its significant
genes were declared significant by both the fixed effects
and random effects meta-analyses.
These results demonstrate how a meta-analysis handles
discrepancies between labs. A meta-analysis can be useful
in finding genes that are statistically significantly differen-
tially expressed and not just declared significant by one or
more labs due to random variation between labs. For
example, lab 1 declared 46 genes significant and lab 2
declared 49 genes significant, but these two labs declared
only 33 of the same genes significant (Table 1). These 33
are not necessarily the most significant in either lab. That
is, the 33 are not necessarily the genes with the smallest
lab 1 P-values or smallest lab 2 P-values, but are those
genes with the smallest P-values from both labs. Alterna-
tively, rather than considering all genes declared signifi-
cant by any of the labs, the random effects meta-analysis
combines information across all six labs in a well-struc-
tured manner and declares 72 genes significantly differen-
tially expressed.
While the numbers of correctly identified differentially
expressed genes do not vary drastically between the indi-
vidual labs (Table 1), the meta-analyses tend to correctly
identify a higher number of differentially expressed genes.
A comparison of the results from this SLR-based meta-
analysis with the results from a previously-proposed
meta-analysis approach based on combining P-values [2]
is also summarized in Table 1. A slight modification to
this P-value approach was necessary to account for differ-
ences in experimental design. Where the previous
approach implicitly required multiple control and experi-
mental sample arrays from each lab, this simulation data
(as well as the real data presented subsequently in this
work) did not satisfy this requirement in all labs. To mod-
ify the previous approach for the current data, probe-spe-
cific perfect match (PM) intensity differences between the
experimental and control conditions were used to obtain
a paired t statistic. Then the same permutation approach
[2] was used to obtain a significance P-value for each gene
in each laboratory based on this paired t statistic, and
these P-values were combined across laboratories as previ-
ously proposed. In general, the SLR-based approach pre-
sented here tended to result in more genes found
significantly differentially expressed by the meta-analysis
than this previously proposed P-value approach (Table 1).
In addition, the P-value approach does not provide a final
quantitative estimate of the degree of differential expres-
sion for each gene, as does the currently proposed SLR-
based approach. The meta-analysis SLR estimates tend to
be much closer to the true SLR values than do the esti-
mates from individual labs (Figure 5).
Integration-Driven Discovery (IDD)
One of the benefits of a meta-analysis is also one of the
benefits of pooling raw data, that is the increased power
to detect significant differences. It is possible that while a
given gene is not declared significantly differentially
expressed by any one lab, the combination of results
across labs in a meta-analysis provides sufficient evidence
to declare significant differential expression. Choi et al.
[3] use the term "Integration-Driven Discovery" (IDD) to
refer to a gene identified as differentially expressed by the
results of a meta-analysis, but not identified as differen-
tially expressed by any of the individual studies or labs. In
this case, the term "integration" is used in the unification
sense rather than the mathematical, since the results of
several different studies are being integrated into a single
meta-analysis.
As shown in Table 2, our particular simulation study pro-
duced 21 IDD's (i.e., 21 of the 72 genes declared
significant by the random effects meta-analysis were not
declared significant by any of the six labs). Of these 21
IDD's, 6 were truly differentially expressed; that is, our
simulation study produced 6 true IDD's and 15 false
IDD's. An examination of the SLR estimates for these IDD
genes (Figure 4c) indicated that IDD's will tend to occur
when 'small but consistent' [3] effect size estimates are
combined. In addition, high variability of each lab's esti-
HZ
0BMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
Page 11 of 19
(page number not for citation purposes)
Bubble plots from the simulation example Figure 4
Bubble plots from the simulation example. Bubble area is proportional to weights used in the meta-analysis. Dashed 
lines represent the 95 percent confidence interval for the true value of the SLR, adjusted to control the FDR for all 1322 genes 
at 0.05. The red dotted line represents the true SLR value. The green bubbles represent labs which claimed significant differen-
tial expression for the gene. When zero lies outside the confidence interval, the meta-analysis declares the gene significantly 
differentially expressed. (a) SLR estimates from the six labs for a particular gene, with fixed effects weights. (b) Plot for the 
same gene as in (a), but with random effects weights. (c) Plot for one of the twenty-one Integration-Driven Discovery (IDD) 
genes declared significant by none of the six simulated labs but significant by the random effects meta-analysis. (d) Plot for one 
of the four Integration-Driven Revision (IDR) genes declared significant by multiple labs but not significant by the random 
effects meta-analysis.
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Table 1: Comparison of results from the simulated data. Comparison of numbers of genes in common declared significant (i.e., 
significantly differentially expressed) by simulated labs 1 through 6, the SLR-based fixed effexts and random effects meta-analyses, and 
the previously proposed P-value-based meta-analysis [2]. The (i, j)th element of this table is the number of genes declared significant by 
both lab i and lab j, with F here representing the fixed effects meta-analysis, R the random effects meta-analysis, and T the "truth" 
behind the simulation model. P represents the meta-analysis based on P-values [2]. Each lab (and meta-analysis) had the False 
Discovery Rate (FDR) controlled at 0.05.
Simulated Lab Meta-Analysis
123456 F i x e d R a n d o m P - v a l u e T r u t h
1 4 63 33 43 43 13 14 33 53 33 5
2 4 93 43 73 13 44 73 93 53 8
3 5 43 43 23 64 44 13 84 1
4 5 13 03 54 83 83 53 9
5 4 43 23 93 73 43 7
6 58 48 40 37 41
F 137 72 45 58
R 72 45 56
P 45 45
T 70
Comparison of SLR estimates with true values from simulation example Figure 5
Comparison of SLR estimates with true values from simulation example. Green squares represent type I errors, 
genes incorrectly claimed as differentially expressed. Red triangles represent type II errors, genes incorrectly claimed to be not 
significantly differentially expressed. The SLR estimates from the random effects meta-analysis tend to approximate the true 
values much better than does any single lab.
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mate may cause individual labs to not declare a gene sig-
nificant while the meta-analysis estimate will have a lower
variance, making a declaration of significance more likely.
Integration-Driven Revision (IDR)
In the simulation results presented here, there were 4
genes declared significant by at least two of the simulated
labs that were not declared significant by the random
effects meta-analysis (Table 2). A closer examination of
the SLR estimates for these particular genes (Figure 4d)
revealed that while at least two of the labs individually
declared the gene significant, the SLR estimates between
the six labs differed sufficiently to make the variance of
the meta-analysis SLR estimate large. This increased vari-
ance of the meta-analysis SLR estimate caused the meta-
analysis to declare these genes not significant. In addition,
some labs' variability estimates may be artificially low due
to chance, thus forcing a false declaration of differential
expression at the individual lab level. The random effects
meta-analysis is able to account for this possibility by
down-weighting overly influential results.
We introduce the term "Integration-Driven Revision"
(IDR) to describe a gene identified as differentially
expressed by multiple studies or labs, but determined by
the results of a meta-analysis to be not differentially
expressed. While multiple laboratories might promote
such a gene for further study because of its large and sig-
nificant effect size, the meta-analysis would conclude that,
due to the inconsistencies in effect sizes across labs, the
gene is not significantly differentially expressed. Whereas
Integration-Driven Discoveries (IDD's) will tend to occur
when 'small but consistent' [3] effect size estimates are
combined, Integration-Driven Revisions (IDR's) will tend
to occur when large but inconsistent effect size estimates
are combined. Of the 4 IDR's made in this simulated
study, 3 were not truly differentially expressed; that is, our
simulation study made 3 true IDR's and 1 false IDR's.
As noted previously, the simulation parameters can be
adjusted to introduce varying degrees of difference
between experiments. Increased inter-laboratory variabil-
ity, or greater inconsistency among effect size estimates,
will tend to affect the numbers of IDD's and IDR's made
by the meta-analysis. Because IDD's occur when effect size
estimates are small but consistent and IDR's occur when
effect size estimates are large but inconsistent, greater
inter-laboratory variability will tend to result in fewer
IDD's and more IDR's being made.
Real data example
Several laboratories have investigated the genetic basis for
EAE (experimental autoimmune encephalomyelitis, the
mouse model for human multiple sclerosis) by use of
Affymetrix technology, and have reported their findings in
published papers [25-29]. In each of these published
papers, mention is made of appropriate care of the mice
following the ethics guidelines at the respective institu-
tions. The three laboratories providing data are Offner
[26,29], Carmody [28], and Ibrahim [25,27]. Each
laboratory measured gene expression in a base (naive or
control) sample and in an experimental (EAE-induced)
sample, with some laboratories using multiple experi-
ments. For the current purposes, an "experiment" is a sin-
gle array-to-array comparison to study differential
expression. Seven total experiments from the three labora-
tories are summarized in Table 3. While not all labs used
the same measure of differential expression in their publi-
cations, here the Affymetrix MAS 5.0 algorithm [11] pro-
Table 2: Summary of results for the simulated data. Numbers of genes declared significant (i.e., significantly differentially expressed) 
by different numbers of labs and the fixed and random effects meta-analyses in the simulation example. The False Discovery Rate 
(FDR) for the meta-analyses and each lab separately was controlled at 0.05. There were 21 Integration-Driven Discoveries (IDD's) and 
4 Integration-Driven Revisions (IDR's).
Fixed Effects Model Random Effects Model
Num. of Labs Declaring Number of Genes Declared Number of Genes Declared
Significance Not Significant Significant Not Significant Significant
01 1 5 2 5 1 1 1 8 2 21
1 3 33 86 4 7
2384 4
30404
40303
50707
60 2 6 0 2 6
1188 137 1250 72BMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
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vides the SLR estimates for each lab from the respective
raw data sets.
The use of different Affymetrix chip versions presents a
non-trivial challenge in comparing and combining results
across laboratories. The same gene may be represented on
two different chip versions, and yet the names reported by
the two chips may differ. Also, different sets of probes may
represent the same gene on different chip versions, result-
ing in different probe set names on different chip ver-
sions. For example, the gene 1200011I18Rik  on chip
Mu11KsubA is identified by Probe Set ID AA000151_at,
while on chip MG_U74Av2 it is Probe Set ID 104759_at.
Furthermore, different chip versions may have different
sets of genes represented on them. In order to combine
the results across labs (and consequently, across chip ver-
sions), each gene must have a "name" recognized by all
chips in the meta-analysis.
Previous meta-analyses of microarray results ([2,6], for
example) have relied on Unigene cluster numbers to
essentially achieve a uniform gene naming scheme across
chip versions and platform types. Other recent work [30]
proposed combining raw data from common probes into
new probesets based on Unigene clusters. Because the
focus of the current work is on combining the results of
the Affymetrix algorithms, SLR estimates corresponding to
the same Unigene cluster numbers are combined across
all experiments. This approach will allow a gene to have
multiple SLR estimates (corresponding to different origi-
nal probe set names) from the same experiment. The Uni-
gene number corresponding to each probe set on an array
is available through the NetAffx feature [31] of the
Affymetrix website [8].
There were considerable differences in the SLR estimates
from the different labs, as represented in Figure 6. Some
of these differences may be due to the use of different
mouse strains, tissue types, and chip versions in the differ-
ent laboratories. However, even experiments from the
same laboratory tended to show disagreement, highlight-
ing the need for biological replicates to provide more pre-
cise estimates of the degree of differential expression for
each gene. This inter-laboratory variability also illustrates
the need for methods to systematically combine results
across laboratories. The fixed effects and random effects
meta-analysis models were employed to combine these
estimates across all laboratories for each Unigene number.
Similar to Table 1 for the simulated example, Table 4 sum-
marizes the overlap in the numbers of genes declared sig-
nificantly differentially expressed by each experiment in
this observed data example. Based on the results of the
random effects model, 3,671 genes are identified as statis-
tically significantly differentially expressed. There were
12,775 unique Unigene numbers represented by the
genes across all arrays in this meta-analysis, so approxi-
mately 28.7% of the genes represented were declared
significantly differentially expressed. This may support the
prediction made by Carmody et al. [28] that about 28.9%
of the genes in the mouse genome 'may be relevant for
autoimmune inflammation', or affected by EAE. Similar
to the simulated data (Table 1), a comparison of the
results from this SLR-based meta-analysis with the results
from an implementation of the previously proposed P-
value approach [2] indicates that even with real data, the
SLR-based approach tends to identify more genes as sig-
nificantly differentially expressed (Table 4).
As in the simulated data, the meta-analysis of these
observed data produced Integration-Driven Discoveries
(IDD's) and Integration-Driven Revision (IDR's). Similar
to Table 2 for the simulated data, Table 5 summarizes
these findings for the observed data. There were 65 IDD's
and 5518 IDR's made. Of the IDR's, 32 were made for
genes declared significantly differentially expressed by all
seven experiments but not by the random effects meta-
analysis. Figure 7 presents bubble plots for representative
IDD and IDR genes from the observed data, similar to Fig-
ure 4 for the simulated data. As in the simulated data,
IDD's tend to occur when small but consistent effect sizes
are combined, and IDR's tend to occur when large but
Table 3: Summary of observed data for the EAE example. A summary of the seven observed experiments involving EAE data to be 
combined in a meta-analysis.
Lab Experiment ID Base Sample Experimental Sample Chip Version
Offner Of.1 Of 1. Naive Of1.EAE1 MG_U74Av2
Offner Of.2 Of2.Naivel Of2.EAEl MG_U74Av2
Offner Of.3 Of2.Naive2 Of2.EAE2 MG_U74Av2
Carmody Ca.1 Ca.Naive1 Ca.Acute1 MG_U74A
Carmody Ca.2 Ca.Naive2 Ca.Acute2 MG_U74A
Ibrahim Ib.A Ib.ControlA Ib.PeakA Mu11KsubA
Ibrahim Ib.B Ib.ControlB Ib.PeakB Mu11KsubBBMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
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inconsistent effect sizes are combined. (See Additional file
1 : EAE.Random.Effects.Results.csv for the final estimates
for all 12,775 genes.)
Discussion
Before any clinical decision is made based on the results
of a meta-analysis, a biological validation of the results
should be performed. Microarray technology is well-
Comparison of SLR estimates from two experiments in the EAE example Figure 6
Comparison of SLR estimates from two experiments in the EAE example. This plot illustrates the variation between 
experiments and the consequent need for a method of systematically combining results from different experiments.
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suited for hypothesis generation, and a meta-analysis can
be used to effectively combine results across multiple
laboratories to refine the list of candidate genes deserving
biological validation. This approach will tend to yield
more informative results when each lab has used biologi-
cal and technical replicates in their experimental design
[32]. The use of replicates at the laboratory level provides
both added power to detect differential expression and
more precise estimation of the true degree of differential
expression for each gene under consideration.
The model used to generate data for the simulation exam-
ple can be adjusted to account for various sources of
variation and relationships between genes. It is of great
interest to investigate how such relationships affect the
outcome of a meta-analytic approach. An extension of the
fixed effects and random effects models to the hierarchical
Bayes approach is also being investigated with the hope of
improving the meta-analysis approach as applied to
microarrays and to incorporate prior knowledge. Included
in this extension is the use of covariates in the meta-anal-
ysis framework to account for known differences between
labs and the appropriate modeling of possible depend-
Table 4: Comparison of results from the EAE example. Comparison of numbers of genes in common declared significant (i.e., 
significantly differentially expressed) by the observed experiments, the SLR-based fixed effects and random effects meta-analyses, and 
the previously proposed P-value-based meta-analysis [2]. Each experiment (and meta-analysis) had the False Discovery Rate (FDR) 
controlled at 0.05.
Observed Experiment ID Meta-Analysis
Ib.A Ib.B Ca.1 Ca.2 Of.1 Of.2 Of.3 Fixed Random P-value
Ib.A 2952 402 1327 1253 1474 1354 1349 2336 1216 265
Ib.B 2902 996 950 1093 1067 1065 2456 1546 236
Ca.1 4471 2834 2797 2476 2461 3548 1555 402
Ca.2 4165 2646 2301 2324 3243 1464 333
Of.1 5001 2763 2807 3834 1578 355
Of.2 4911 3035 3669 1344 335
Of.3 5041 3728 1289 305
F 8263 3623 388
R 3671 205
P 453
Table 5: Summary of results from the EAE example. Numbers of genes declared significantly differentially expressed by different 
numbers of experiments and the fixed and random effects meta-analyses in the observed data example. The False Discovery Rate 
(FDR) for the meta-analyses and each experiment separately was controlled at 0.05. There were 65 Integration-Driven Discoveries 
(IDD's) and 5518 Integration-Driven Revisions (IDR's). There were 32 IDR's that had been declared significantly differentially 
expressed by all seven experiments.
Fixed Effects Model Random Effects Model
Number of Experiments 
Declaring
Number of Genes Declared Number of Genes Declared
Significance Not Significant Significant Not Significant Significant
0 1792 301 2028 65
1 804 2265 1558 1511
2 749 1409 1869 289
3 625 1512 1662 475
4 328 1319 1084 563
5 152 908 617 443
6 54 464 254 264
78 8 5 32 61
4512 8263 9104 3671BMC Bioinformatics 2005, 6:57 http://www.biomedcentral.com/1471-2105/6/57
Page 17 of 19
(page number not for citation purposes)
ence among effect size estimates. We feel the use of covari-
ates will provide insight into the effects of different labs,
tissues, and microarray platforms on the observed differ-
ential expressions of genes. Separating out the effects of
these covariates will facilitate the identification of those
genes which are differentially expressed between two con-
ditions rather than appearing differentially expressed due
to external influences such as lab, tissue, or platform. For
example, the differences observed between experiments
from the same laboratory (Table 4) may be explained by
differences in mouse strain or tissue sample, and the
inclusion of covariate information in the model would
adjust for this.
In the examples presented here, all studies involved used
the Affymetrix platform and the data were summarized
using the same normalization strategy with the MAS 5.0
algorithm [11]. When multiple studies have employed
different platforms (such as cDNA and other oligonucle-
otide arrays) or normalization strategies, then some
adjustments to the approach presented here will be neces-
sary. In particular, a readily-available quantitative meas-
ure of differential expression common to all platforms
involved is needed. In addition, it will be of great interest
to consider the effect of a platform covariate in the
extended meta-analysis model.
Although we have demonstrated our approach using both
simulated rat data and real observed data from essentially
genetically homogeneous mice, its utility with human
data is of great interest. Along with the increased variabil-
ity in human data comes an increase in the information
about each individual subject and subpopulation. There-
fore the incorporation of such covariate information is an
important subject of our future work. We anticipate that
the use of covariate information with human data will be
particularly informative in identifying biologically signif-
icant subpopulations - for example, in identifying genes
that are related to a disease in one subpopulation but not
in another.
Bubble plots from the EAE example Figure 7
Bubble plots from the EAE example. Bubble area is proportional to weights used in the meta-analysis. Dashed lines rep-
resent the 95 percent confidence interval for the true value of the SLR, adjusted to control the FDR for all 1322 genes at 0.05. 
The green bubbles represent experiments which claimed significant differential expression for the gene. When zero lies outside 
the confidence interval, the meta-analysis declares the gene significantly differentially expressed. (a) Bubble plot for one of the 
sixty-five Integration-Driven Discovery (IDD) genes declared significant by none of the seven observed experiments but signif-
icant by the random effects meta-analysis. (b) Bubble plot for one of the thirty-two Integration-Driven Revision (IDR) genes 
declared significant by all seven observed experiments but not significant by the random effects meta-analysis.
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Conclusion
The signal log ratio (SLR), automatically reported by MAS
5.0 [11], is naturally suited to serve as an effect size esti-
mate in a meta-analysis of results from multiple laborato-
ries. In order to perform a meta-analysis of microarray
results as presented here, the following components are
needed for each probe set from each experiment: the cor-
responding Unigene ID, the SLR estimate, and the esti-
mated variance of the SLR estimate. The random effects
meta-analysis model is better suited than the fixed effects
model for the analysis of microarray results because of the
lack of homogeneity of effects from different laboratories.
Genes not declared significantly differentially expressed
by any single lab but then declared significantly differen-
tially expressed by the meta-analysis are referred to as Inte-
gration-Driven Discoveries, or IDD's [3]. In addition to
the identification of IDD's, our meta-analysis method
identified genes declared significantly differentially
expressed by multiple (and possibly all) laboratories but
not significantly differentially expressed by the meta-anal-
ysis. These genes are referred to as Integration-Driven
Revisions, or IDR's. The simulation example demon-
strated how the final SLR estimates from the meta-analysis
models tend to be much closer to the "true" SLR values
than do the SLR estimates from any single lab. These
meta-analytic approaches to microarray results provide a
systematic method to combine results from different lab-
oratories with the purpose of gaining clearer insight into
the true degree of differential expression for each gene.
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